Evidence map›Paper›PMID 39810159›Full record

ArticleAIDS research and therapy2025

95-95-95 HIV indicators among children younger than 15 years in South Africa: results from the 2017 national HIV prevalence, incidence, behaviour, and communication survey.

Rindidzani E Magobo, Musawenkosi Mabaso, Sean Jooste, Lesiba Molopa, Inbarani Naidoo, Leickness Simbayi, Khangelani Zuma, Nompumelelo Zungu, Olive Shisana, Sizulu Moyo

Abstract read
In one paragraph

Article in AIDS research and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Low metformin concentrations in obese people with HIV treated with dolutegravir.African journal of primary health care & family medicine · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. "SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rindidzani E MagoboHuman Sciences Research Council, Pretoria, South Africa. RMagobo@hsrc.ac.za.
Musawenkosi MabasoHuman Sciences Research Council, Pretoria, South Africa.
Sean JoosteHuman Sciences Research Council, Pretoria, South Africa.
Lesiba MolopaHuman Sciences Research Council, Pretoria, South Africa.
Inbarani NaidooHuman Sciences Research Council, Pretoria, South Africa.
Leickness SimbayiHuman Sciences Research Council, Pretoria, South Africa.
Khangelani ZumaHuman Sciences Research Council, Pretoria, South Africa.
Nompumelelo ZunguHuman Sciences Research Council, Pretoria, South Africa.
Olive ShisanaDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
Sizulu MoyoHuman Sciences Research Council, Pretoria, South Africa.

Funding

President's Emergency Plan for AIDS Relief (PEPFAR) through the Centres for Disease Control and Prevention (CDC) 5U2GGH000570
6 · The paper itself

Abstract

backgroundEarly detection and initiation of care is crucial to the survival and long-term well-being of children living with HIV (CLHIV). However, there remain challenges regarding early testing and linking of CLHIV for early treatment. This study examines the progress made towards achieving the 95-95-95 HIV indicators and associated factors among CLHIV < 15 years in South Africa.

methodsThe data was collected as part of the 2017 cross-sectional, multistage cluster randomized population-based household National HIV survey. Age-appropriate structured questionnaires were utilized to gather sociodemographic data, HIV-related knowledge, risk behaviours, and health-related information. Blood samples were collected to test for HIV serology, viral load suppression, and antiretroviral usage. Backward stepwise multivariable generalized linear regression models were fitted to identify factors associated with the 95-95-95 HIV indicators. Adjusted odds ratios (AOR) with 95% confidence intervals (CI) are shown, and p < 0.05 indicates statistical significance.

resultsA total of 12,237 CLHIV < 15 years were included (median 8 years, interquartile range 4-11 years). HIV prevalence was 2.8% (95% CI: 2.4-3.3). Overall, 40.0% of the CLHIV were tested and knew their status (first 95%), and among these, 72.6% (95% CI: 61.7-81.3) were on antiretroviral therapy (ART) (second 95%), and 95.0% (95% CI: 88.4-97.9) of these were virally suppressed (third 95%). Among CLHIV, the odds of testing and knowing the HIV-positive status were significantly higher among children whose health was rated as fair/poor than excellent/good [AOR = 1.32 (95%CI: 1.05-1.67), p = 0.022], and were significantly lower among females than males [AOR = 0.82 (95% CI: 0.71-0.95), p = 0.009], and were significantly lower among those attending private healthcare facilities than public health facilities [AOR = 0.64 (95% CI:0.57-0.74), p < 0.001]. Among those who knew their HIV-positive status, the odds of being on ART were significantly higher among children residing in farm areas than urban areas [AOR = 1.40 (95% CI:1.05-1.86), p = 0.017], and were significantly lower among children attending private healthcare facilities [AOR = 0.44 (95% CI:0.36-0.54), p < 0.001].

conclusionsAwareness of HIV status and initiation of treatment in children was low. The findings highlight the need to improve HIV status awareness and disclosure to children. The findings underscore the need for targeted interventions and programs tailored for CLHIV in urban areas.

Indexed as

HIV InfectionsAdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansIncidenceInfantMalePrevalenceSouth AfricaSurveys and QuestionnairesViral LoadARTHIVViral suppression, children

Identifiers

PMID39810159
PMCPMC11731543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.